Calliditas Therapeutics AB Overview
Calliditas Therapeutics AB Target Price
Analysts' 12-month price predictions for CALT.
Get informed when a big investor buys or sells
+ FollowShare Price
$40
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-05-28 | JefferiesMaury Raycroft | $39 |  2.5% downside |  |
| 2024-05-28 | Stifel NicolausAnnabel Samimy | $40 |  0% upside | |
| 2024-05-23 | JefferiesMaury Raycroft | $58 | 45% upside | |